Home › Pharmaceuticals › Therapeutic/drugs
Therapeutic/drugs Market Research Reports & Consulting
The drug manufacturers are suffering due to raising costs attributed to increasing complexities in clinical trials. Hence speedy adoption of new technologies is very essential for market players to optimize their costs and to have a competitive edge in the market. Innovation in breakthrough technologies has widened the market scope for therapeutics and drugs market. There has been signification shift in focus from providing general drugs and therapy to providing drugs for target cluster and personalized therapies. This is attributed to market transition from pharmaceutical to biotechnology. Enhancing technologies impacting high growth markets such as proteomics, genomics, and personalized medicines have led a long way in introducing effective drugs and therapies. Increasing regulations imposed on drug development process have created a demand for automated tools such as bioinformatics that can store analytical data and facilitate the researcher to design and develop effective drugs. Entry of generic drugs that are less expensive has posed threat to the market players in the drugs market. Increasing safety requirement and legislation is furthermore adding pressure on the drug and therapy providers to increase efficiency. Enhancing Drug development technologies and emerging concepts in life sciences have a greater role in such complicated environment.
Market Reports
| Title | Published | Price | TOC Available |
|---|---|---|---|
Acute Myeloid Leukemia Therapeutics Market in G8 Countries (2010 - 2020)Acute myeloid leukemia is the second frequent type (after acute lymphocytic leukemia) of leukemia diagnosed in infants. About 15% of children from birth to 19 years of age diagnosed with leukemia have acute myeloid leukemia. The risk of acute myeloid leukemia is closely associated with age. About 90% of acute myeloid leukemia is diagnosed in middle age. Incidence rate of acute myeloid leukemia is high in men and women over 50 years. The acute myeloid leukemia market is segmented into two types; namely childhood acute myeloid leukemia and adulthood acute myeloid leukemia. The market was dominated by AVD regimen in 2010. However, in 2020, the market is expected to be dominated by AVD regimen, Cyatarabine, and Quizartinib drug. |
December 2011 | $ 4650 |
|
Chronic Lymphocytic Leukemia Therapeutics Market in G8 Countries (2010 - 2020)Chronic lymphocytic leukemia is the second most common cancer in adult males and rarely occurs in children. The risk of chronic lymphocytic leukemia is closely associated with age. About 90% of chronic lymphocytic leukemia is diagnosed in middle age. Incidence rate of CLL is high in men and women over 50 years of age. The chronic lymphocytic leukemia market is segmented into two types; namely childhood chronic lymphocytic leukemia and adulthood lymphocytic leukemia. The market was dominated by Campath drug in 2010. However, in 2020, the market is expected to be equally dominated by GA101/RG7159 molecule and Arzerra drug. |
December 2011 | $ 4650 |
|
Acute Lymphocytic Leukemia Therapeutics Market (Pipeline Forecast & Market Forecast in G8 Countries) (2010 - 2020)The incidence of acute lymphocytic leukemia is high in children from 0 to 14 years than the people aged above 14. It is the most common childhood acute lymphocytic leukemia. However, the acute lymphocytic leukemia may also occur in adults. Acute lymphocytic leukemia distribution depends on age. For instance, 30% of is diagnosed before the age of 5 and 55% of ALL age 15.The acute lymphocytic leukemia market is segmented into two types; namely childhood acute lymphocytic leukemia, and adult acute lymphocytic leukemia. The market was dominated by Hyper-CVAD regimen in 2010. However, in 2020, the market is expected to be equally dominated by Hyper-CVAD and Linker regimen. |
December 2011 | $ 4650 |
|
Leukemia Therapeutics Market (2010-2020) (Acute/Chronic Lymphocytic Leukemia & Acute/Chronic Myeloid Leukemia) Pipeline Forecast & Market Forecast in G8 CountriesLeukemia is the type of blood cancer and the ninth most common one in males. It accounts for almost 0.0148% of all the men and 0.009% of all the women worldwide. The leukemia market is segmented into four types; namely acute lymphocytic leukemia, chronic lymphocytic leukemia, acute myeloid leukemia, and chronic myeloid leukemia. The market was dominated by chronic myeloid leukemia in 2010. However, in 2020, the market is expected to be equally dominated by acute lymphocytic leukemia and chronic myeloid leukemia. |
November 2011 | $ 6500 |
|
Global Fetal (Labor & Delivery) and Neonatal Care Equipment Market (2011-2016)This report studies the global fetal and neonatal care market divided into global NICU equipment market, global labor and delivery equipment market, and global other labor & delivery equipment & NICU equipment market over the forecasted period (2011-2016). The global NICU equipment market was worth $1.4 billion in 2011; growing at a steady pace of 6.4% CAGR to reach $1.9 billion in 2016. |
September 2011 | $ 4650 |
|
Global Respiratory Care Devices Market (2010 – 2015)The global respiratory care devices market has grown significantly over past few years and is expected to grow at a steady pace in the coming five years. Rapidly aging population, rising incidence in Chronic Obtrusive Pulmonary Diseases (COPD), technical advances in respiratory care devices market and tight budget faced by healthcare institutions are the major factors influencing the market. |
April 2011 | $ 4650 |
|
BRIC Diabetes Drugs Market (2010-2015) in Brazil, Russia, India, ChinaThe prevalence of diabetes is increasing globally with the increase in life expectancy and rising incidence of obesity. Brazil’s diabetes drugs market is showing a double digit growth rate; while the Russian insulin market is also expected to witness significant growth with an estimated over 20 million patients in the region requiring diabetes treatment by 2025. India and China have the highest number of diabetics in the world – China alone is expected to have more than 71 million diabetic patients by 2025; and the similarly huge patient-base in India has already attracted a number of pharmaceutical companies such as Eli Lilly and Novo Nordisk. These companies are offering easy-to-use insulin versions to grab the market share in the Indian market for diabetes drugs. Thus, diabetes drugs market in BRIC economies is expected to have significant growth opportunities in the years to come. |
April 2010 | $ 4650 |
|
Autoimmune Treatment Market (2009 - 2014)The report sizes the market for the diagnosis and therapeutic technologies for the auto immune diseases. It also tracks the advances in the technologies along with the profiles and strategies of the key players in this market. The report highlights the new approaches being pursued in this market. |
September 2009 | $ 4650 |
|
Global Weight Loss and Diet Management Market (2009 - 2014)Obesity and weight gain issues have always been a major concern impacting the health and fitness of the individuals. Increasing awareness levels among the appearance and calorie conscious consumers has opened up new avenues and opportunities to this market. The rate of new product entry in the weight management segment is significantly high, necessitating industry participants to adopt proactive strategies and keep ahead of competition. |
July 2009 | $ 4650 |
|
Anti Nicotine Therapies (2010 - 2015)Smoking cessation products are gaining popularity in both OTC and prescription products market segments. Increasing burden on healthcare system due to deteriorating quality of life because of smoking and several side effects associated with the current smoking cessation marketed products, builds up the need of novel products with better efficacy in this market. |
March 2012 | $ 4650 | |
Monoclonal Antibodies Market (2010 - 2015)The global market for diagnostic and therapeutic market is expected to exceed $ 25 million market by the end of 2010. mAbs held the top 3 ranks among the top selling brands in 2008. Monoclonal antibodies present significant opportunities as they are targeted therapy (They impact only the diseased cells and do not harm healthy cells) unlike chemotherapy drugs. |
March 2012 | $ 4650 | |
Global Oncology Pharmaceuticals & Therapeutics MarketEach section of the report offers market data with respect to segments and geography. It also provides market trends with respect to drivers, restraints and opportunities. The report contains strategic section with respect to competitive landscape and market overview. The report will encompass more than 40 company profiles. |
March 2012 | $ 4650 | |
Cardiovascular Therapy - Advanced Technologies And Global Market (2010 - 2015)The research report outlines the latest developments in the cardiovascular therapy industry across the globe. The market data includes innovative technologies, key players, market trends and opportunities, drivers and challenges are clearly identified and examined. |
March 2012 | $ 4650 |
Custom Research
We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.
Please visit http://www.marketsandmarkets.com/custom-research.asp to specify your custom Research Requirement
Connect Us
